Efstathios Karathanasis
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
- Biomaterials 28
- Nanoparticle-Based Drug Delivery 28
-
- Nanoplatforms for cancer theranostics 17
- Nanopore and Nanochannel Transport Studies 6
- Co-authors
- Randall Toy (9 shared papers)Ketan B. Ghaghada (11 shared papers)Pubudu M. Peiris (17 shared papers)Ananth Annapragada (12 shared papers)Ravi V. Bellamkonda (8 shared papers)Lisa Bauer (6 shared papers)Elliott Hayden (4 shared papers)Gil Covarrubias (16 shared papers)
- Journals
- Journal of Controlled Release (6 papers)PLoS ONE (4 papers)ACS Nano (4 papers)Nanoscale (4 papers)Advanced Drug Delivery Reviews (2 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Efstathios Karathanasis
49 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 111
- Biomaterials 1.3k
- Biomedical Engineering 1.3k
- Pharmaceutical Science 137
- Immunology 305
- Immunology and Allergy 66
Countries citing papers authored by Efstathios Karathanasis
This map shows the geographic impact of Efstathios Karathanasis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efstathios Karathanasis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efstathios Karathanasis more than expected).
Fields of papers citing papers by Efstathios Karathanasis
This network shows the impact of papers produced by Efstathios Karathanasis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efstathios Karathanasis. The network helps show where Efstathios Karathanasis may publish in the future.
Co-authors
The 25 scholars most cited alongside Efstathios Karathanasis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 466 | |
| 2 | 2011 | 197 | |
| 3 | 2012 | 146 | |
| 4 | 2014 | 137 | |
| 5 | 2015 | 108 | |
| 6 | 2012 | 105 | |
| 7 | 2009 | 104 | |
| 8 | 2009 | 81 | |
| 9 | 2019 | 75 | |
| 10 | 2016 | 64 | |
| 11 | 2015 | 60 | |
| 12 | 2009 | 56 | |
| 13 | 2013 | 53 | |
| 14 | 2020 | 51 | |
| 15 | 2020 | 49 | |
| 16 | 2008 | 49 | |
| 17 | 2015 | 46 | |
| 18 | 2004 | 46 | |
| 19 | 2018 | 45 | |
| 20 | 2019 | 44 |
About Efstathios Karathanasis
Efstathios Karathanasis is a scholar working on Biomaterials, Biomedical Engineering, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 2.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (28 papers), Nanoplatforms for cancer theranostics (17 papers), Immunotherapy and Immune Responses (7 papers), Nanopore and Nanochannel Transport Studies (6 papers), Glioma Diagnosis and Treatment (6 papers), Inhalation and Respiratory Drug Delivery (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cell Adhesion Molecules Research (4 papers). The work is most often cited by research in Biomaterials (1.3k citations), Biomedical Engineering (1.3k citations), Pharmaceutical Science (137 citations), Immunology (305 citations) and Immunology and Allergy (66 citations). Efstathios Karathanasis has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Randall Toy, Ketan B. Ghaghada, Pubudu M. Peiris, Ananth Annapragada, Ravi V. Bellamkonda, Lisa Bauer, Elliott Hayden, Gil Covarrubias, Prabhani U. Atukorale and Harihara Baskaran. Their work appears in journals such as Journal of Controlled Release, PLoS ONE, ACS Nano, Nanoscale and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.